Pfizer Vs Moderna Vs Johnson & Johnson

Jun 29, 2021 3:00 PM ET
Campaign: CSRHub Research

Pfizer Vs Moderna Vs Johnson & Johnson

Those interested in sustainability should be interested in a different way of comparing the major vaccines.

Vaccine-producing companies have made huge contributions to fighting the COVID plague. They have spent millions of dollars developing and manufacturing products that have only moderate financial benefit, but deliver big social value.

Working with Skytop Strategies, CSRHub took a look at the ESG data on three major vaccine manufactures. Our article digs below the top level rankings (when the study was done, J&J was at 96%, Pfizer Inc 87%, and Moderna Inc 52%) to understand what factors drive how these companies are perceived.

We hope comparing these three producers will give you insight on ratings process in general and on how CSRHub generates its aggregate scores. 

Pfizer Versus Moderna Versus Johnson & Johnson on Skytop Strategies

Bahar Gidwani is CTO and Co-founder of CSRHub.  He has built and run large technology-based businesses for many years. Bahar holds a CFA, worked on Wall Street with Kidder, Peabody, and with McKinsey & Co. Bahar has consulted to a number of major companies and currently serves on the board of several software and Web companies. He has an MBA from Harvard Business School and an undergraduate degree in physics and astronomy. He plays bridge, races sailboats, and is based in New York City.

About CSRHub

CSRHub offers one of the world’s broadest and most consistent set of Environment, Social, and Governance (ESG) ratings, covering 20,000 companies. Its Big Data algorithm combines millions of data points on ESG performance from hundreds of sources, including leading ESG analyst raters, to produce consensus scores on all aspects of corporate social responsibility and sustainability. CSRHub ratings can be used to drive corporate, investor and consumer decisions. For more information, visit CSRHub is a B Corporation.